Serum sodium ion level influenced by daily salt intake after administration of sodium-glucose cotransporter 2 inhibitors

Nutrition. 2018 Jan:45:146. doi: 10.1016/j.nut.2017.05.008. Epub 2017 May 31.

Authors

Eijiro Yamada¹, Aya Osaki¹, Tsugumichi Saito¹, Yawara Niijima², Junichi Okada¹, Shuichi Okada¹, Masanobu Yamada¹

Affiliations

¹ Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan.
² Kan-etsu Chuo Hospital, Gunma, Japan.

PMID: 28689689
DOI: 10.1016/j.nut.2017.05.008

No abstract available

Publication types

Letter

MeSH terms

Aged
Blood Glucose / metabolism
Blood Pressure / drug effects
Body Mass Index
Canagliflozin / administration & dosage
Cholesterol / blood
Diabetes Mellitus, Type 2 / blood
Female
Follow-Up Studies
Glycated Hemoglobin / metabolism
Humans
Hypoglycemic Agents / administration & dosage*
Male
Sodium / blood*
Sodium Chloride, Dietary / administration & dosage*
Sodium-Glucose Transporter 2 / metabolism
Sodium-Glucose Transporter 2 Inhibitors*
Triglycerides / blood

Substances

Blood Glucose
Glycated Hemoglobin A
Hypoglycemic Agents
SLC5A2 protein, human
Sodium Chloride, Dietary
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors
Triglycerides
Canagliflozin
Cholesterol
Sodium